Product Life-Cycle Management for Generic Pharmaceuticals (Sixth Edition)

The Generic Challenge, now in its Sixth Edition, offers crucial updates on the contemporary regulatory, legal, and commercial issues impacting brand and generic pharmaceutical products. This comprehensive work explores the recent laws establishing generics for biologics, as well as the changes introduced by the recently enacted America Invents Act.

Clearly and comprehensively, the book elucidates the roles of patents, FDA drug regulation, and the Hatch-Waxman Act in the commercial development of drugs, in the face of generic challenges. It demonstrates how advancements in innovative drug products not only benefit patients but also extend the commercial viability of these drugs.

The book delves into the intricate interplay between patent protection, regulatory approval, and the delicate balance between brand-name and generic pharmaceuticals. It examines the complex landscape of biologic drugs and the emergence of biosimilars, providing insights into the evolving legal and regulatory frameworks governing these cutting-edge therapies.

Moreover, the Sixth Edition explores the implications of the America Invents Act, a landmark piece of legislation that has significantly altered the intellectual property landscape for pharmaceutical companies. The book offers a comprehensive analysis of how these changes have impacted the development and commercialization of both brand-name and generic drugs.

Importantly, The Generic Challenge is the only resource of its kind, offering a comprehensive and authoritative perspective on this critical subject matter. By addressing the multifaceted issues surrounding generic pharmaceutical challenges, the book equips readers with a deep understanding of the evolving legal, regulatory, and commercial forces shaping the pharmaceutical industry.

Whether you are a pharmaceutical executive, a legal professional, a regulatory expert, or a student of the industry, The Generic Challenge is an indispensable reference that provides invaluable insights and strategies for navigating the complex and ever-changing landscape of brand-name and generic drug development and commercialization.

product information: